CN103432405B - 一种治疗嗜食肥肉型腋下急性化脓性淋巴结炎的中药 - Google Patents
一种治疗嗜食肥肉型腋下急性化脓性淋巴结炎的中药 Download PDFInfo
- Publication number
- CN103432405B CN103432405B CN201310367487.2A CN201310367487A CN103432405B CN 103432405 B CN103432405 B CN 103432405B CN 201310367487 A CN201310367487 A CN 201310367487A CN 103432405 B CN103432405 B CN 103432405B
- Authority
- CN
- China
- Prior art keywords
- grams
- herba
- radix
- addicted
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 36
- 210000001099 axilla Anatomy 0.000 title claims abstract description 24
- 235000013372 meat Nutrition 0.000 title claims abstract description 24
- 230000001154 acute effect Effects 0.000 title claims abstract description 22
- 201000009052 suppurative lymphadenitis Diseases 0.000 title claims abstract description 22
- 238000011282 treatment Methods 0.000 title claims abstract description 21
- 235000013305 food Nutrition 0.000 title claims abstract description 20
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 241000746375 Andrographis Species 0.000 claims abstract description 7
- 241000959626 Calvatia Species 0.000 claims abstract description 7
- 241001094455 Cipangopaludina chinensis Species 0.000 claims abstract description 7
- 241001250596 Pleione Species 0.000 claims abstract description 7
- 210000000582 semen Anatomy 0.000 claims abstract description 7
- 241000563984 Ampelopsis Species 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 6
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 229940126678 chinese medicines Drugs 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 3
- 229940079593 drug Drugs 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 9
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 3
- 239000003242 anti bacterial agent Substances 0.000 abstract description 2
- 229940088710 antibiotic agent Drugs 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 231100000614 poison Toxicity 0.000 description 43
- 239000003440 toxic substance Substances 0.000 description 40
- 210000004185 liver Anatomy 0.000 description 33
- 210000004072 lung Anatomy 0.000 description 32
- 230000001737 promoting effect Effects 0.000 description 30
- 208000004880 Polyuria Diseases 0.000 description 25
- 235000009508 confectionery Nutrition 0.000 description 25
- 230000035619 diuresis Effects 0.000 description 25
- 208000002193 Pain Diseases 0.000 description 24
- 239000008280 blood Substances 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 21
- 210000000952 spleen Anatomy 0.000 description 19
- 210000002784 stomach Anatomy 0.000 description 19
- 210000002429 large intestine Anatomy 0.000 description 18
- 210000002216 heart Anatomy 0.000 description 16
- 230000023597 hemostasis Effects 0.000 description 16
- 230000008961 swelling Effects 0.000 description 15
- 230000001939 inductive effect Effects 0.000 description 12
- 238000001816 cooling Methods 0.000 description 11
- 206010062717 Increased upper airway secretion Diseases 0.000 description 9
- 206010030113 Oedema Diseases 0.000 description 9
- 208000026435 phlegm Diseases 0.000 description 9
- 206010020751 Hypersensitivity Diseases 0.000 description 8
- 230000007815 allergy Effects 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 208000026935 allergic disease Diseases 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 229930182555 Penicillin Natural products 0.000 description 5
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 5
- 238000010255 intramuscular injection Methods 0.000 description 5
- 239000007927 intramuscular injection Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229940049954 penicillin Drugs 0.000 description 5
- 230000007096 poisonous effect Effects 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000007803 itching Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 231100000167 toxic agent Toxicity 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 208000015817 Infant Nutrition disease Diseases 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000000812 cholinergic antagonist Substances 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000010985 leather Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000002048 spasmolytic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSCN1C(=O)[C@H]1NC(=O)CC1 UUTKICFRNVKFRG-WDSKDSINSA-N 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000010000 Agranulocytosis Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010009657 Clostridium difficile colitis Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010011509 Crystalluria Diseases 0.000 description 1
- 206010011894 Deafness permanent Diseases 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 206010018687 Granulocytopenia Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033661 Pancytopenia Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 1
- 206010037128 Pseudomembranous colitis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 229940075522 antidotes Drugs 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 1
- 229960003644 aztreonam Drugs 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960004682 cefoperazone Drugs 0.000 description 1
- GCFBRXLSHGKWDP-XCGNWRKASA-N cefoperazone Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 GCFBRXLSHGKWDP-XCGNWRKASA-N 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000860 cochlear nerve Anatomy 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000002895 emetic Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 229960002292 piperacillin Drugs 0.000 description 1
- WCMIIGXFCMNQDS-IDYPWDAWSA-M piperacillin sodium Chemical compound [Na+].O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C([O-])=O)C(C)(C)S[C@@H]21 WCMIIGXFCMNQDS-IDYPWDAWSA-M 0.000 description 1
- ZRHANBBTXQZFSP-UHFFFAOYSA-M potassium;4-amino-3,5,6-trichloropyridine-2-carboxylate Chemical compound [K+].NC1=C(Cl)C(Cl)=NC(C([O-])=O)=C1Cl ZRHANBBTXQZFSP-UHFFFAOYSA-M 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
年龄(岁) | 23~30 | 31~40 | 41~50 | 51~68 |
例数 | 11 | 219 | 127 | 12 |
百分比 | 3% | 59.3% | 34.4% | 3.3% |
疗效 | 治愈 | 好转 | 无效 |
例数 | 366 | 3 | 无 |
百分比 | 99.2% | 0.8% | 无 |
治疗天数 | 3~5 | 6~9 | 10~14 | 15~26 |
例数 | 16 | 219 | 121 | 13 |
百分比 | 4.3% | 59.3% | 32.8% | 3.6% |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310367487.2A CN103432405B (zh) | 2013-08-22 | 2013-08-22 | 一种治疗嗜食肥肉型腋下急性化脓性淋巴结炎的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310367487.2A CN103432405B (zh) | 2013-08-22 | 2013-08-22 | 一种治疗嗜食肥肉型腋下急性化脓性淋巴结炎的中药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103432405A CN103432405A (zh) | 2013-12-11 |
CN103432405B true CN103432405B (zh) | 2015-08-19 |
Family
ID=49686189
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310367487.2A Expired - Fee Related CN103432405B (zh) | 2013-08-22 | 2013-08-22 | 一种治疗嗜食肥肉型腋下急性化脓性淋巴结炎的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103432405B (zh) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101396508B (zh) * | 2008-10-06 | 2010-11-17 | 赵庆军 | 一种治疗急性淋巴结炎的中药制备方法 |
CN103251772A (zh) * | 2013-04-30 | 2013-08-21 | 何良爱 | 一种治疗嗜食大蒜型脓性指头炎的中药洗剂制备方法 |
CN103251748A (zh) * | 2013-05-25 | 2013-08-21 | 王德章 | 一种治疗过食熏肉型贲门炎的中药制备方法 |
CN103251749A (zh) * | 2013-05-25 | 2013-08-21 | 靳先玲 | 一种治疗过食肥肉型贲门炎的中药制备方法 |
CN103251808A (zh) * | 2013-05-25 | 2013-08-21 | 高建芬 | 一种治疗嗜食高热食品型贲门炎的中药制备方法 |
-
2013
- 2013-08-22 CN CN201310367487.2A patent/CN103432405B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN103432405A (zh) | 2013-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102743633B (zh) | 一种治疗腐肉型蜂窝组织炎的中药洗剂制备方法 | |
CN102743630B (zh) | 一种治疗嗜食大蒜型蜂窝组织炎的中药洗剂制备方法 | |
CN103463523B (zh) | 一种治疗热毒炽盛型腋下急性化脓性淋巴结炎中药 | |
CN103463447A (zh) | 一种治疗目赤型前庭大腺炎的中药洗剂制备方法 | |
CN103463370B (zh) | 一种治疗嗜食牛肚型腋下急性化脓性淋巴结炎的中药 | |
CN103432405B (zh) | 一种治疗嗜食肥肉型腋下急性化脓性淋巴结炎的中药 | |
CN103463337B (zh) | 一种治疗经络阻滞型腋下急性化脓性淋巴结炎的中药 | |
CN103230543A (zh) | 一种治疗嗜食芥茉型脓性指头炎的中药洗剂制备方法 | |
CN103446479B (zh) | 一种治疗过食油炸食物型腋下急性化脓性淋巴结炎的中药 | |
CN103446480B (zh) | 一种治疗过食熏鸡型腋下急性化脓性淋巴结炎的中药 | |
CN103432451B (zh) | 一种治疗过食猪大肠型腋下急性化脓性淋巴结炎的中药 | |
CN103432408B (zh) | 一种治疗痰浊壅塞型腋下急性化脓性淋巴结炎的中药 | |
CN103463336B (zh) | 一种治疗过食川椒型腋下急性化脓性淋巴结炎的中药 | |
CN103432406A (zh) | 一种治疗肿块型腋下急性化脓性淋巴结炎的中药制备方法 | |
CN103463433A (zh) | 一种治疗口渴型腋下急性化脓性淋巴结炎的中药制备方法 | |
CN103463434A (zh) | 一种治疗发热型腋下急性化脓性淋巴结炎的中药制备方法 | |
CN103432409B (zh) | 一种治疗嗜食烤肉型腋下急性化脓性淋巴结炎的中药 | |
CN103432454A (zh) | 一种治疗酗酒型腋下急性化脓性淋巴结炎的中药制备方法 | |
CN103446533B (zh) | 一种治疗肝郁化火型腋下急性化脓性淋巴结炎的中药 | |
CN103432407B (zh) | 一种治疗过食猪肝型腋下急性化脓性淋巴结炎的中药 | |
CN103432483A (zh) | 一种治疗瘀血型腋下急性化脓性淋巴结炎的中药制备方法 | |
CN103479925A (zh) | 一种治疗痰火内扰型前庭大腺炎的中药洗剂制备方法 | |
CN103463435A (zh) | 一种治疗过食芥茉型腋下急性化脓性淋巴结炎的中药 | |
CN103463431A (zh) | 一种治疗过食干姜型腋下急性化脓性淋巴结炎的中药 | |
CN103463436A (zh) | 一种治疗过食咸鱼型腋下急性化脓性淋巴结炎的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LI LING WANG HONGAI ZHANG ZHIHU ZHANG CHAOPENG LIU Effective date: 20150715 Owner name: WEI PING Free format text: FORMER OWNER: WANG ENLE Effective date: 20150715 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wei Ping Inventor after: Li Lian Inventor after: Wang Hongai Inventor after: Zhang Zhihu Inventor after: Zhang Chaopeng Inventor after: Liu Ming Inventor before: Wang Enle |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG ENLE TO: WEI PING LI LING WANG HONGAI ZHANG ZHIHU ZHANG CHAOPENG LIU MING |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150715 Address after: Huaiyin District of Ji'nan City, Shandong province 250117 Ji No. 440 Yan Lu Tumor Hospital of Shandong Province Applicant after: Wei Ping Applicant after: Li Lian Applicant after: Wang Hongai Applicant after: Zhang Zhihu Applicant after: Zhang Chaopeng Applicant after: Liu Ming Address before: 250200 Zhangqiu people's Hospital, Ji'nan, Shandong Applicant before: Wang Enle |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150819 Termination date: 20160822 |
|
CF01 | Termination of patent right due to non-payment of annual fee |